22 results
6-K
STVN
Stevanato Group Spa
9 May 24
Current report (foreign)
4:10pm
innovation, acceleration and expansion of vaccination programs, growth in biologics/biosimilars, self-administration of medicines, aging demographics
424B5
STVN
Stevanato Group Spa
25 Mar 24
Prospectus supplement for primary offering
4:04pm
, growth of biologics/biosimilars, self-administration of medicines, aging demographics, increasing complexities in health conditions and co
424B5
STVN
Stevanato Group Spa
20 Mar 24
Prospectus supplement for primary offering
5:16pm
/biosimilars, self-administration of medicines, aging demographics, increasing complexities in health conditions and co-morbidities, and increasing quality
6-K
STVN
Stevanato Group Spa
3 Nov 23
Current report (foreign)
4:00pm
/biosimilars, self-administration of medicines, aging demographics, increasing quality standards and regulation and a shift towards outsourcing non-core
6-K
EX-99.1
aurbh 24kg0y0y46z
28 Sep 23
Current report (foreign)
9:31am
6-K
iwa1d16hi80e gnz
2 Aug 23
Current report (foreign)
9:25am
6-K
5cb9g9tf0 3c4lel936
4 May 23
Current report (foreign)
7:49am
6-K
tfnal ml3dg
8 Nov 22
Current report (foreign)
6:47am
6-K
t084n2xrzb eobl
4 Aug 22
Current report (foreign)
6:47am
6-K
8i50y1
10 May 22
Current report (foreign)
8:20am
6-K
EX-99.2
ukjdu4681tc qhz
6 May 22
Ordinary and Extraordinary Shareholders’ Meeting
6:07am
20-F/A
4jpqlj
5 Apr 22
Annual report (foreign) (amended)
7:14am
20-F
cmsk4cvr3 nwo2ou3l
8 Mar 22
Annual report (foreign)
6:50am
6-K
bei7 hohfnzt0yyyua
9 Nov 21
Current report (foreign)
4:35pm
6-K
gwiha
23 Aug 21
Current report (foreign)
10:27am
424B4
64uzx9chv
16 Jul 21
Prospectus supplement with pricing info
2:18pm
F-1/A
ni55uycqp1na 6pvo
12 Jul 21
Registration statement (foreign) (amended)
7:22am
F-1/A
drs2wwj5ara4cvaia0
7 Jul 21
Registration statement (foreign) (amended)
9:59am
F-1
ntij43niqytbo6
21 Jun 21
Registration statement (foreign)
8:54am